Medplus Share Price
(MEDPLUS)
Check the latest share price of Medplus, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹820.35
▲1.04%
as on 04:01PM, 29 Apr 2025
NSE
Medplus Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹811.9Day's Price Range₹838.7552 Week's Low
52 Week's High
₹61652-Week Price Range₹875.65
| Returns % | |
| 1 Month Return | + 12.74 % |
| 3 Month Return | -1.08 % |
| 1 Year Return | + 15.14 % |
| Market Stats | |
| Previous Close | ₹811.90 |
| Open | ₹812.40 |
| Volume | 1.29L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹9,446.24Cr |
Medplus Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹9,446.24 Cr
Return on Equity (ROE)
0.63
Return on capital employed (ROCE)
0.9
P/B Ratio
10.83
EPS (TTM)
7.94
Sector
Retail
How to invest in Medplus
Investing in Medplus is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Medplus or MEDPLUS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Medplus or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Medplus with just a few clicks!
Medplus Valuation
Track how the P/E of Medplus has moved over time to understand valuation trends.
Medplus in the last 5 years
Lowest (81.79x)
June 14, 2022
Industry (-318.32x)
December 15, 2023
Today (153.56x)
December 15, 2023
Highest (263.63x)
March 17, 2023
Today’s Price to Earnings Ratio: 153.56x
Analysts Recommendation on Medplus
Get updated buy, sell, and hold recommendations by analysts on Medplus.
based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Medplus. Average target of ₹980.4
Source: S&P Global Market Intelligence
Analysts Forecast on Medplus
Get share price movements and forecasts by analysts on Medplus.
Medplus price forecast by 5 analysts
Upside of24.23%
High
₹1045
Target
₹980.40
Low
₹930
Medplus target price ₹980.4, a slight upside of 24.23% compared to current price of ₹820.35. According to 5 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medplus revenue growth forecast
Expected growth rate Q1, FY2025:60.53%
Forecast
Actual
Including amortisation and stock based compensations
Medplus EPS growth forecast
EPS estimate Q1, FY2025:169.30%
Forecast
Actual
Source: S&P Global Market Intelligence
Medplus Financials
Get the annual and quarterly financial summary of Medplus, including revenue, profit, loss and more.
Medplus Index Inclusions
Medplus Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medplus.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 40.43% | 0.00 | |
| Foreign Institutions | 4.49% | 0.00 | |
| Mutual Funds | 12.21% | 0.00 | |
| Retail Investors | 26.73% | 0.00 | |
| Others | 16.14% | 0.00 |
Medplus vs Peers
Compare market cap, revenue, PE, and other key metrics of Medplus with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹9,446.24 Cr | -5.92% | 0.52 | NA | NA | |
| NA | ₹40.17 Cr | -18.83% | 0.86 | NA | NA | |
| NA | ₹15.61 Cr | -5.54% | 0.50 | NA | NA |
Medplus News & Key Events
Latest news and events at one place to help you take investing decisions in Medplus.
MedPlus Subsidiary Faces Drug License Suspensions - 21 Apr, 2025
MedPlus Health Services Ltd's subsidiary, Optival Health Solutions, has received drug license suspensions for one and three days at two stores in Karnataka, potentially leading to revenue losses of Rs 1.45 lacs. This situation underscores regulatory compliance challenges.Analyst Recommends Buy for Medplus Health Services - 15 Apr, 2025
On April 15, 2025, an analyst suggested buying Medplus Health Services shares at ₹760, targeting ₹865-885, citing strong investor interest and consistent revenue growth. Key metrics include a P/E of 32.4 and a 52-week high of ₹1,215.MedPlus Subsidiary Faces Drug License Suspensions - 12 Apr, 2025
MedPlus Health Services Ltd's subsidiary, Optival Health Solutions, has received drug license suspensions for two stores in Andhra Pradesh and Karnataka, potentially leading to a revenue loss of Rs 3.04 lacs. This regulatory challenge may impact the company's financial operations and market positioning.MedPlus Subsidiary Faces Drug License Suspensions - 24 Mar, 2025
MedPlus Health Services Ltd's subsidiary, Optival Health Solutions, has received drug license suspensions in Karnataka and Maharashtra, potentially leading to revenue losses of approximately Rs 10.72 lacs. This regulatory challenge may impact the company's financial operations and market positioning.
Insights on Medplus Health Services Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, MEDPLUS has outperformed top 5 stocks with highest market-cap in Drug Retailers
- POSITIVE IMPACT
Price Rise
In the last 6 months, MEDPLUS stock has moved up by 24.8%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 14.36 Cr → 45.89 Cr (in ₹), with an average increase of 39.3% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 21.51% to 21.59% in Mar 2025 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 15.23% to 15.61% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Muller & Phipps India Ltd has given 88.9% return, outperforming this stock by 107.3%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 18.69% to 17.82% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 40.39% to 40.34% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.58K Cr → 1.57K Cr (in ₹), with an average decrease of 0.9% per quarter
About Medplus
The company's retail pharmacy offers an extensive selection of prescription and over-the-counter medicines, including popular brands such as Pfizer, Novartis, and GlaxoSmithKline. It also stocks a wide range of health and wellness products, including vitamins, supplements, and herbal products.
Medplus also offers a variety of healthcare services, including home nursing, physiotherapy, and medical equipment rental. Its diagnostic services include X-ray, ultrasound, and lab tests. The company also provides health check-up packages and health insurance services.
Revenue: ₹1,488.83Cr as on June 2024 (Q2 24)
Net Profit: ₹14.34Cr as on June 2024 (Q2 24)
Listing date: 23 Dec, 2021
Chairperson Name: GANGADI MADHUKAR REDDY
| Organisation | Medplus |
| Headquarters | |
| Industry | Retail |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Medplus
Check out the Mutual Funds with significant holdings in Medplus.
Futures and Options
View the latest movement in Medplus Futures & Options, including strike prices, expiry dates, and percentage changes.
FAQs
What is Medplus Health Services Ltd price today?
Medplus Health Services Ltd share price today stands at ₹820.35, Open: ₹812.4, Previous Close: ₹811.9, High: ₹838.75, Low: ₹811.9, 52 Week High: ₹875.65, 52 Week Low: ₹616.
How to Buy Medplus Health Services Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Medplus Health Services Ltd shares
What are today's traded volumes of Medplus Health Services Ltd?
Today's traded volume of Medplus Health Services Ltd(MEDPLUS) is 1.29L.
What is today's market capitalisation of Medplus Health Services Ltd?
Today's market capitalisation of Medplus Health Services Ltd(MEDPLUS) is ₹9,446.24 Cr.
What is the 52 Week High and Low Range of Medplus Health Services Ltd?
How much percentage Medplus Health Services Ltd is down from its 52 Week High?
Medplus Health Services Ltd (MEDPLUS) share price is ₹820.35. It is down -6.32% from its 52 Week High price of ₹875.65
How much percentage Medplus Health Services Ltd is up from its 52 Week low?
Medplus Health Services Ltd (MEDPLUS) share price is ₹820.35. It is up 33.17% from its 52 Week Low price of ₹616